Seroepidemiological Study of Herpes Simplex Virus Infection (I) Age Distribution of the Neutralizing and Complement-fixing Antibody to Herpes Simplex Virus (type I)
Syoichi Sawanobori
Pediatrics International 14(1): 11-12
1972
ISSN/ISBN: 1328-8067
DOI: 10.1111/j.1442-200x.1972.tb02378.x
Accession: 061300324
PDF emailed within 0-6 h: $19.90
Related References
Syoichi Sawanobori 1973: Seroepidemiological Study of Herpes Simplex Virus Infection (2) Age Distribution of Neutralizing Antibody to Herpes Simplex Virus Type I and Type 2 Pediatrics International 15(2): 16-17Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Sasagawa, A.; Suzuki, M.; Narita, T.; Honjo, S.; Kalter, S.S. 1986: Herpes simplex virus complement fixing antibody and herpes B virus serum neutralizing antibody in sera of wild and laboratory-bred cynomolgus monkeys Jikken Dobutsu. Experimental Animals 35(1): 59-63
Kimura, S.; Okazaki, K. 1984: Expression of a herpes simplex virus glycoprotein in two clonal lines of hamster cells transformed by herpes simplex virus type 2 - Expression d'une glycoprotéine du virus herpès simplex dans deux lignées clonales de cellules de hamster transformées par le virus herpès simplex de type 2 Gann 75(4): 317-324
Rabenau, H. F.; Helmerich, A.; Weber, B. 1999: Verbesserte Labordiagnose der Herpes simplex Virus Infektion: Evaluierung eines modifizierten schnellen Shell-Vial-Assays zur Detektion und Typisierung von Herpes simplex Viren. Improved Laboratory Diagnosis of Herpes Simplex Virus Infection: Evaluation of a Modified Rapid Shell-Vial-Assay for the Detection and Typing of Herpes Simplex Virus Laboratoriums Medizin 23(11): 614-620
Bernstein, D.I.; Stanberry, L.R.; Harrison, C.J.; Kappes, J.C.; Myers, M.G. 1986: Antibody response recurrence patterns and subsequent herpes simplex virus type 2 re infection following initial herpes simplex virus type 2 infection of guinea pigs effects of acyclovir Journal of General Virology 67(8): 1601-1612
Gold, D.; Ashley, R.; Solberg, G.; Abbo, H.; Corey, L. 1988: Chronic-dose acyclovir to suppress frequently recurring genital herpes simplex virus infection: effect on antibody response to herpes simplex virus type 2 proteins Journal of Infectious Diseases 158(6): 1227-1234
Wilkie, N.M.; Stow, N.D.; Marsden, H.S.; Preston, V.; Cortini, R.; Timbury, M.C.; Subak Sharpe, J.H. 1979: Physical mapping of herpes simplex virus coded functions and poly peptides by marker rescue and analysis of herpes simplex virus type 1 herpes simplex virus type 2 inter typic recombinants De-The, G , W Henle And F Rapp (Ed ) IARC (International Agency For Research on Cancer) Science Publications, No 24 Oncogenesis And Herpesviruses, Iii Part 1: Dna Of Herpesviruses, Viral Antigens, Cell-Virus Interaction; Proceedings Of The 3rd International Symposium, Cambridge, Mass , Usa, July 25-29, 1977 Lv+580p International Agency For Research on Cancer: Lyon, France Illus P11-32, 1978
Carter, V.C.; Jennings, S.R.; Rice, P.L.; Tevethia, S.S. 1984: Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytes Journal of Virology 49(3): 766-771
Sherlock, C.H.; Ashley, R.L.; Shurtleff, M.L.; Mack, K.D.; Corey, L. 1986: Type specificity of complement-fixing antibody against herpes simplex virus type 2 AG-4 early antigen in patients with asymptomatic infection Journal of Clinical Microbiology 24(6): 1093-1097
Althof, F.; Mechtersheimer, M.; Richter, M.; Dietz, A. 2000: Ein Herpes-simplex-Virus Typ 1-induzierter, Tumor im Vestibulum nasi: Die Problematik der Resistenzentwicklung von Herpes-simplex-Viren im Rahmen einer chronisch-lymphatischen B-Zell-Leukämie - Herpes simplex virus type 1-induced, tumor in the nasal vestibule.the problem of resistance development of herpes simplex in a patient with chronic lymphatic B-cell leukemia Hno. Hals-, Nasen-, Ohrenarzte 48(2): 147-151
Ohashi, M.; Ozaki, Y. 1982: Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay Microbiology and Immunology 26(7): 569-574
Kawana, R.; Sato, H.; Sato, N. 1972: Distribution of complement-requiring neutralizing antibody against herpes simplex virus in human population Japanese Journal of Microbiology 16(5): 447-449
Ghiasi, H.; Cai, S.; Slanina, S.; Nesburn, A.B.; Wechsler, S.L. 1997: Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations IOVS Investigative Ophthalmology and Visual Science 38(6): 1213-1221
Arsenakis, M.; May, J.T. 1981: Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients Infection and Immunity 33(1): 22-28